Pulmotect
Dr. Evans is a physician-scientist at the University of Texas MD Anderson Cancer Center. A pulmonary medicine expert with a specialized interest in pneumonia, he runs an NIH-funded laboratory that investigates innate immune responses in the lungs. Work in Dr Evans’ laboratory lead to the discovery of Pulmotect’s lead compound, PUL-042. His team remains focused on exploring the mechanisms that underlie inducible resistance, in order to efficiently harness the remarkable protection associated with this phenomenon.
This person is not in the org chart
This person is not in any offices
Pulmotect
Pulmotect develops products that boost the innate immune system to protect against a wide range of lung infections.